[DPHARMA] QoQ Quarter Result on 31-Mar-2023 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Mar-2023 [#1]
Profit Trend
QoQ- 31.89%
YoY- 11.54%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 167,501 169,235 167,516 200,475 151,960 177,074 181,742 -5.28%
PBT 7,034 11,427 16,515 28,292 15,347 21,385 21,473 -52.38%
Tax 1,468 -2,457 -3,974 -5,659 1,814 -5,036 -5,162 -
NP 8,502 8,970 12,541 22,633 17,161 16,349 16,311 -35.15%
-
NP to SH 8,502 8,970 12,541 22,633 17,161 16,349 16,311 -35.15%
-
Tax Rate -20.87% 21.50% 24.06% 20.00% -11.82% 23.55% 24.04% -
Total Cost 158,999 160,265 154,975 177,842 134,799 160,725 165,431 -2.60%
-
Net Worth 682,979 673,359 670,448 666,567 657,045 647,522 634,375 5.03%
Dividend
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Div 17,314 - 4,788 - 17,140 - 4,734 136.82%
Div Payout % 203.66% - 38.19% - 99.88% - 29.02% -
Equity
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Net Worth 682,979 673,359 670,448 666,567 657,045 647,522 634,375 5.03%
NOSH 961,942 961,942 961,942 952,239 952,239 952,239 952,239 0.67%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 5.08% 5.30% 7.49% 11.29% 11.29% 9.23% 8.97% -
ROE 1.24% 1.33% 1.87% 3.40% 2.61% 2.52% 2.57% -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 17.41 17.59 17.49 21.05 15.96 18.60 19.19 -6.26%
EPS 0.88 0.93 1.31 2.38 1.80 1.72 1.72 -35.95%
DPS 1.80 0.00 0.50 0.00 1.80 0.00 0.50 134.34%
NAPS 0.71 0.70 0.70 0.70 0.69 0.68 0.67 3.93%
Adjusted Per Share Value based on latest NOSH - 952,239
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
RPS 17.40 17.58 17.40 20.83 15.79 18.39 18.88 -5.28%
EPS 0.88 0.93 1.30 2.35 1.78 1.70 1.69 -35.19%
DPS 1.80 0.00 0.50 0.00 1.78 0.00 0.49 137.51%
NAPS 0.7095 0.6995 0.6965 0.6924 0.6825 0.6726 0.659 5.03%
Price Multiplier on Financial Quarter End Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 -
Price 1.26 1.20 1.30 1.56 1.61 1.30 1.20 -
P/RPS 7.24 6.82 7.43 7.41 10.09 6.99 6.25 10.26%
P/EPS 142.56 128.69 99.28 65.63 89.34 75.72 69.66 60.98%
EY 0.70 0.78 1.01 1.52 1.12 1.32 1.44 -38.09%
DY 1.43 0.00 0.38 0.00 1.12 0.00 0.42 125.81%
P/NAPS 1.77 1.71 1.86 2.23 2.33 1.91 1.79 -0.74%
Price Multiplier on Announcement Date
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Date 22/02/24 08/11/23 24/08/23 22/05/23 23/02/23 09/11/22 16/08/22 -
Price 1.21 1.22 1.19 1.44 1.65 1.39 1.34 -
P/RPS 6.95 6.93 6.80 6.84 10.34 7.47 6.98 -0.28%
P/EPS 136.90 130.83 90.88 60.59 91.56 80.96 77.78 45.62%
EY 0.73 0.76 1.10 1.65 1.09 1.24 1.29 -31.51%
DY 1.49 0.00 0.42 0.00 1.09 0.00 0.37 152.47%
P/NAPS 1.70 1.74 1.70 2.06 2.39 2.04 2.00 -10.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment